Skip to main content
Article
Heterozygous De Novo UBTF Gain-of-Function Variant Is Associated with Neurodegeneration in Childhood.
American Journal of Human Genetics
  • Simon Edvardson, Hadassah-Hebrew University Medical Center
  • Claudia M Nicolae, The Pennsylvania State University College of Medicine
  • Pankaj B Agrawal, Harvard Medical School
  • Cyril Mignot, Centre de Référence des Déficiences Intellectuelles de Causes Rares
  • Katelyn Payne, Riley Hospital for Children
  • Asuri Narayan Prasad, Western University
  • Chitra Prasad, Western University
  • Laurie Sadler, State University of New York
  • Caroline Nava, Sorbonne Universités
  • Thomas E Mullen, Broad Institute of MIT and Harvard
  • Amber Begtrup, GeneDx
  • Berivan Baskin, GeneDx
  • Zöe Powis, Ambry Genetics
  • Avraham Shaag, adassah-Hebrew University Medical Center
  • Boris Keren, Centre de Référence des Déficiences Intellectuelles de Causes Rares
  • George-Lucian Moldovan, The Pennsylvania State University College of Medicine
  • Orly Elpeleg, Hadassah-Hebrew University Medical Center
Document Type
Article
Publication Date
8-3-2017
URL with Digital Object Identifier
https://doi.org/10.1016/j.ajhg.2017.07.002
Disciplines
Abstract

Ribosomal RNA (rRNA) is transcribed from rDNA by RNA polymerase I (Pol I) to produce the 45S precursor of the 28S, 5.8S, and 18S rRNA components of the ribosome. Two transcription factors have been defined for Pol I in mammals, the selectivity factor SL1, and the upstream binding transcription factor (UBF), which interacts with the upstream control element to facilitate the assembly of the transcription initiation complex including SL1 and Pol I. In seven unrelated affected individuals, all suffering from developmental regression starting at 2.5-7 years, we identified a heterozygous variant, c.628G>A in UBTF, encoding p.Glu210Lys in UBF, which occurred de novo in all cases. While the levels of UBF, Ser388 phosphorylated UBF, and other Pol I-related components (POLR1E, TAF1A, and TAF1C) remained unchanged in cells of an affected individual, the variant conferred gain of function to UBF, manifesting by markedly increased UBF binding to the rDNA promoter and to the 5'- external transcribed spacer. This was associated with significantly increased 18S expression, and enlarged nucleoli which were reduced in number per cell. The data link neurodegeneration in childhood with altered rDNA chromatin status and rRNA metabolism.

Citation Information
Simon Edvardson, Claudia M Nicolae, Pankaj B Agrawal, Cyril Mignot, et al.. "Heterozygous De Novo UBTF Gain-of-Function Variant Is Associated with Neurodegeneration in Childhood." American Journal of Human Genetics Vol. 101 Iss. 2 (2017) p. 267 - 273
Available at: http://works.bepress.com/chitra-prasad/27/